Formulation Development

EXCLUSIVE ONLINE CONTENT

10/18/2018

Arcis Biotechnology & Teleflex Sign License Agreement  

Arcis Biotechnology recently announced it has signed a technology access agreement with Teleflex Incorporated. Teleflex will harness Arcis’ advanced nucleic acid sample preparation chemistry in the development of a novel technology, which it believes will be disruptive, and is intended to empower clinicians and drive better patient outcomes.